Patents Assigned to University of Pa.
  • Patent number: 8295575
    Abstract: This invention relates to computer-assisted diagnostics and classification of prostate cancer. Specifically, the invention relates to segmentation of the prostate boundary on MRI images, cancer detection using multimodal multi-protocol MR data; and their integration for a computer-aided diagnosis and classification system for prostate cancer.
    Type: Grant
    Filed: October 29, 2008
    Date of Patent: October 23, 2012
    Assignees: The Trustees of the University of PA., Rutgers, The State University of New Jersey
    Inventors: Michael D. Feldman, Satish Viswanath, Pallavi Tiwari, Robert Toth, Anant Madabhushi, John Tomaszeweski, Mark Rosen
  • Publication number: 20030100998
    Abstract: A system and method used to assess animal behavior includes a module having sensors that collects a variety of physical and biological data from a test subject. Interpretation of the data is provided to assess the test subject's behavior, neurology, biochemistry and physiology. The module is useful in observing the effects of a drug on the test animal and providing information on the drug's signature. Another advantage is module's portability that allows it to be used in standard laboratory cages. This portability allows the animal to be tested in its own habitat, that can reduce any erroneous data due to stressing the animal when removed to a test cage. Additionally, the module's design allows for parallel data collection and interpretation from several laboratory animals undergoing different experiments. Multi-dimensional modeling of the test subject based the system's interpretation of the data allows pattern recognition of the drug signature, and predictive drug analysis.
    Type: Application
    Filed: May 15, 2002
    Publication date: May 29, 2003
    Applicant: Carnegie Mellon University (Pittsburgh, PA) and PsychoGenics, Inc. (Hawthorne, NY)
    Inventors: Daniela Brunner , Vijay Gondhalekar , Emer Leahy , David LaRose , William P. Ross
  • Patent number: 6303717
    Abstract: Oily hyperbranched polymers derived from ethylene, propylene, butene and/or a C5-C24 &agr;-olefin, and a method for their synthesis, are disclosed. The polymers have non-regular microstructures and are characterized by a ratio ()of methyl hydrogens centered around 0.85 ppm on the 1H-NMR spectra of the polymers relative to total aliphatic hydrogens of from about 0.40 to about 0.65 for polymers derived from ethylene or butene, and a ratio ()of from greater than 0.50 to about 0.65 for polymers derived from propylene. A method for grafting hyperbranched polymers derived from ethylene, propylene, butene and/or a C5-C24 &agr;-olefin onto aromatic rings in organic molecules and polymers, and the resulting grafted materials, are also disclosed. The hyperbranched polymers and grafted materials are useful, for example, as lubricants and lubricant additives.
    Type: Grant
    Filed: February 3, 1998
    Date of Patent: October 16, 2001
    Assignee: The Penn State Research Foundation University Park PA
    Inventors: Ayusman Sen, Jang Sub Kim, James H. Pawlow, Shahid Murtuza, Smita Kacker, Louis M. Wojcinski, III
  • Patent number: 5363864
    Abstract: In thoracoscopic surgery digital palpation of intrathoracic anatomical structures is facilitated by the use of a rigid finger sheath which prevents the forces exerted by the patients ribs from causing numbness in the surgeon's finger. The finger sheath has an enlarged end which prevents it from falling into the patient's thoracic cavity.
    Type: Grant
    Filed: April 27, 1993
    Date of Patent: November 15, 1994
    Assignee: The Trustees of the University of Pennsylvania, University of Pa.-Center for Technology Transfer
    Inventor: Larry R. Kaiser
  • Patent number: 4931403
    Abstract: A novel method of determining the onset of the fertile period of a human female is disclosed comprising the step of monitoring the axillary secretions of said female during the course of her menstrual cycle to determine variations in the concentration of androstenol or dehydroepiandrosterone sulfate. A first significant increase in the concentration of either of those compounds following the cessation of menses is indicative of the onset of the fertile period. In each case, a follicular phase peak occurs which exceeds by at least twice the concentration of those compounds present at any other time during the menstrual cycle. As a result, the monitoring of these compounds may act as reliable indicators predicting the occurrence of ovulation in five to seven days, and/or indicating the onset of the fertile period at a time when appropriate contraceptive measures can still be taken to avoid pregnancy or sexual intercourse can promote fertility.
    Type: Grant
    Filed: August 7, 1989
    Date of Patent: June 5, 1990
    Assignees: Monell Chemical Senses Center, University of Pa.
    Inventors: Winnifred B. Cutler, George Preti, George R. Huggins